Filters
Results 1 - 1 of 1
Results 1 - 1 of 1.
Search took: 0.021 seconds
AbstractAbstract
[en] A newly designed encapsulated 103Pd source has been introduced (BrachySeed trade mark sign -Pd-103, also named Model Pd-1, manufactured by DRAXIMAGE Inc. and distributed by Cytogen Corp.) for interstitial brachytherapy to provide more isotropic dose distributions. In this work, the dosimetric characteristics of the 103Pd source were measured with micro LiF TLD chips and dosimetry parameters were characterized based upon the American Association of Physicists in Medicine (AAPM) Task Group No. 43 formalism. The dose rate constant of the sources was determined to be 0.66±0.05 cGy h-1 U-1. The radial dose function was measured and was found to be similar to that of the Theragenics Model 200 103Pd source. The anisotropy constant for the Model Pd-1 source was determined to be 1.03
Primary Subject
Secondary Subject
Source
(c) 2002 American Association of Physicists in Medicine.; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
Country of publication
BETA DECAY RADIOISOTOPES, DAYS LIVING RADIOISOTOPES, DOSES, DRUGS, ELECTRON CAPTURE RADIOISOTOPES, EVEN-ODD NUCLEI, IMPLANTS, INTERMEDIATE MASS NUCLEI, ISOTOPES, LABELLED COMPOUNDS, MATERIALS, MEDICINE, NUCLEAR MEDICINE, NUCLEI, PALLADIUM ISOTOPES, RADIATION SOURCES, RADIOACTIVE MATERIALS, RADIOISOTOPES, RADIOLOGY, RADIOTHERAPY, THERAPY
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
External URLExternal URL